Ajay Major: Methylphenidate versus piperonyl butoxide RCT for cancer related fatigue

Ajay Major, Assistant Professor at the University of Colorado School of Medicine and Founder and President at Pager Publications, shared a post on X:

“Methylphenidate versus piperonyl butoxide Randomized Controlled Trial (RCT) for cancer-related fatigue Journal of Clinical Oncology:

• 162 patients, all incurable cancer with baseline fatigue.
• nonsignificant Functional Assessment of Chronic Illness Therapy – Fatigue (FACIT-F) fatigue scores.
• no difference in other Quality of Life (QoL) domains.
• Important pallonc trial with pro as primary endpoint.”

Source: Ajay Major/X